Article
Group IIa secretory phospholipase expression correlates with group IIa secretory phospholipase inhibition-mediated cell death in K-ras mutant lung cancer cells.
The Journal of thoracic and cardiovascular surgery - 1 Dec 2012
Yu Jessica A, Li Howard, Meng Xianzhong, Fullerton David A, Nemenoff Raphael A, Mitchell John D, Weyant Michael J
Abstract excerpt
OBJECTIVE: There are currently no targeted therapies against lung tumors with oncogenic K-ras mutations that are found in 25% to -40% of lung cancers and are characterized by their resistance to epidermal growth factor receptor inhibitors. The isozyme group IIa secretory phospholipase A(2) (sPLA(2)IIa) is a potential biomarker and regulator of lung cancer cell invasion; however, the relationship between K-ras...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
